Biodegradable Device Monitors Levels of Pesticides in Fruit, Vegetables

This aerial photograph taken on Oct 31, 2022 shows a farmer spraying pesticide to a crop of cabbage cultivated in his field on the outskirts of Bengaluru. (AFP)
This aerial photograph taken on Oct 31, 2022 shows a farmer spraying pesticide to a crop of cabbage cultivated in his field on the outskirts of Bengaluru. (AFP)
TT

Biodegradable Device Monitors Levels of Pesticides in Fruit, Vegetables

This aerial photograph taken on Oct 31, 2022 shows a farmer spraying pesticide to a crop of cabbage cultivated in his field on the outskirts of Bengaluru. (AFP)
This aerial photograph taken on Oct 31, 2022 shows a farmer spraying pesticide to a crop of cabbage cultivated in his field on the outskirts of Bengaluru. (AFP)

Researchers at the University of São Paulo (USP) and the Federal University of Viçosa (UFV) in Brazil have developed a sustainable sensor that can be placed directly on the surface of a vegetable or fruit to detect the presence of pesticides.

The device has the potential to help ensure food safety in a world that increasingly suffers from a shortage of food and the environmental and health problems caused by excessive use of agrochemicals. The results of the study were published in the journal Biomaterials Advances.

Pesticides are widely used to raise crop yields and are typically applied by spraying, but only 50% reach their target. The rest ends up in soil, groundwater, surface water, raw drinking water, wastewater and food products.

Monitoring of pesticide levels in water, soil and food is therefore essential to prevent contact between these toxic substances and the public via the skin, lungs or digestive system.

The researchers explained that the tools most often used for this purpose are chromatographic techniques (consist of separating and defining chemical compounds), which are effective but have drawbacks such as the need for pretreatment of samples, expensive equipment and qualified laboratory specialists, as well as the long time taken to complete the analysis. The unsafe residues produced by organic solvents are also a significant problem under present-day conditions.

As an alternative, electrochemical sensors can combine affordability, rapid detection, large-scale production, convenience, ease of use, high selectivity and in situ pesticide detection.

“Our invention has all these features. The analysis is performed directly on the surface of fruit, vegetables or leaves. It is made of cellulose acetate, a material derived from wood pulp,” said Paulo Augusto Raymundo-Pereira, co-author of the study.

“Instead of the usual materials, which are environmentally unsustainable and take a long time to degrade, such as ceramics or plastic polymers derived from petroleum, we used cellulose acetate, a material derived from plants that has little impact on the environment and disintegrates completely in 340 days or less depending on local conditions. It also has appropriate characteristics, including low cost, portability and flexibility,” he explained.

The researchers carried out laboratory tests in which a pesticide solution was sprayed on lettuce and tomatoes in a simulation of real-world use. The sensor was then directly attached to the lettuce and tomatoes, and measurements showed a level of detection compatible with those obtained with the sensor material most frequently used for this purpose.

The technology can be useful for sanitary surveillance agencies worldwide, farmers, as well as sellers of organic produce to certify absence of pesticides.



Blood Tests Allow 30-year Estimates of Women's Cardio Risks, New Study Says

A woman jogs in a park in Saint-Sebastien-sur-Loire near Nantes, France January 19, 2024. REUTERS/Stephane Mahe/File Photo Purchase Licensing Rights
A woman jogs in a park in Saint-Sebastien-sur-Loire near Nantes, France January 19, 2024. REUTERS/Stephane Mahe/File Photo Purchase Licensing Rights
TT

Blood Tests Allow 30-year Estimates of Women's Cardio Risks, New Study Says

A woman jogs in a park in Saint-Sebastien-sur-Loire near Nantes, France January 19, 2024. REUTERS/Stephane Mahe/File Photo Purchase Licensing Rights
A woman jogs in a park in Saint-Sebastien-sur-Loire near Nantes, France January 19, 2024. REUTERS/Stephane Mahe/File Photo Purchase Licensing Rights

Women’s heart disease risks and their need to start taking preventive medications should be evaluated when they are in their 30s rather than well after menopause as is now the practice, said researchers who published a study on Saturday.

Presenting the findings at the European Society of Cardiology annual meeting in London, they said the study showed for the first time that simple blood tests make it possible to estimate a woman’s risk of cardiovascular disease over the next three decades.

"This is good for patients first and foremost, but it is also important information for (manufacturers of) cholesterol lowering drugs, anti-inflammatory drugs, and lipoprotein(a)lowering drugs - the implications for therapy are broad," said study leader Dr. Paul Ridker of Brigham and Women’s Hospital in Boston, Reuters reported.

Current guidelines “suggest to physicians that women should generally not be considered for preventive therapies until their 60s and 70s. These new data... clearly demonstrate that our guidelines need to change,” Ridker said. “We must move beyond discussions of 5 or 10 year risk."

The 27,939 participants in the long-term Women’s Health Initiative study had blood tests between 1992 and 1995 for low density lipoprotein cholesterol (LDL-C or “bad cholesterol”), which are already a part of routine care.

They also had tests for high-sensitivity C-reactive protein (hsCRP) - a marker of blood vessel inflammation - and lipoprotein(a), a genetically determined type of fat.

Compared to risks in women with the lowest levels of each marker, risks for major cardiovascular events like heart attacks or strokes over the next 30 years were 36% higher in women with the highest levels of LDL-C, 70% higher in women with the highest levels of hsCRP, and 33% higher in those with the highest levels of lipoprotein(a).

Women in whom all three markers were in the highest range were 2.6 times more likely to have a major cardiovascular event and 3.7 times more likely to have a stroke over the next three decades, according to a report of the study in The New England Journal of Medicine published to coincide with the presentation at the meeting.

“The three biomarkers are fully independent of each other and tell us about different biologic issues each individual woman faces,” Ridker said.

“The therapies we might use in response to an elevation in each biomarker are markedly different, and physicians can now specifically target the individual person’s biologic problem.”

While drugs that lower LDL-C and hsCRP are widely available - including statins and certain pills for high blood pressure and heart failure - drugs that reduce lipoprotein(a) levels are still in development by companies, including Novartis , Amgen , Eli Lilly and London-based Silence Therapeutics.

In some cases, lifestyle changes such as exercising and quitting smoking can be helpful.

Most of the women in the study were white Americans, but the findings would likely “have even greater impact among Black and Hispanic women for whom there is even a higher prevalence of undetected and untreated inflammation,” Ridker said.

“This is a global problem,” he added. “We need universal screening for hsCRP ... and for lipoprotein(a), just as we already have universal screening for cholesterol.”